Concepedia

Rodwige Desnoyer

RD

Statistics

Publications

1

Citations

221

H-Index

1

Active since

2017

Affiliations

Stony Brook University(Current)

Rodwige Desnoyer is an author at Stony Brook University specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

2017–2017

1

Publications

1

Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial

Angela Alistar, Bonny Morris, Rodwige Desnoyer et al. · The Lancet Oncology · 2017 · 221 citations · Full text

, , +9

1–1 of 1